(HPQ) HP - Overview
Sector: Technology | Industry: Computer Hardware | Exchange: NYSE (USA) | Market Cap: 23.170m USD | Total Return: -9.4% in 12m
Avg Turnover: 343M
EPS Trend: -72.6%
Qual. Beats: 1
Rev. Trend: 25.1%
Qual. Beats: 1
Warnings
Altman Z'' -0.84 < 1.0 - financial distress zone
Extended 1w
Tailwinds
No distinct edge detected
HP Inc. (HPQ) is a global provider of personal computing devices, imaging products, and related technologies. The company operates through three primary segments: Personal Systems, Printing, and Corporate Investments. Its product portfolio includes commercial and consumer PCs, workstations, 3D printing solutions, and digital security services aimed at individual consumers, small businesses, and large enterprises.
The hardware sector is characterized by high operational maturity and a shift toward recurring revenue models, such as managed print services and subscription-based ink delivery. HP Inc. maintains a significant market share in the global PC and printing markets, competing primarily on product innovation and supply chain efficiency. To analyze the firms historical performance and valuation metrics, consider reviewing the detailed data available on ValueRay.
Formerly known as Hewlett-Packard Company, the entity rebranded as HP Inc. in 2015 following the separation of its enterprise technology services. The company remains headquartered in Palo Alto, California, focusing on hybrid work solutions and industrial 3D printing applications to drive long-term growth.
- PC refresh cycle and AI-enabled laptop demand drive Personal Systems revenue
- High-margin printing supplies sales volume dictates overall corporate profitability and cash flow
- Cost-saving initiatives and operational transformation programs support operating margin expansion
- Commercial IT spending levels influence enterprise hardware procurement and services growth
- Aggressive capital return strategy through dividends and buybacks maintains shareholder value
| Net Income: 2.51b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.46 > 1.0 |
| NWC/Revenue: -12.56% < 20% (prev -14.11%; Δ 1.54% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.71b > Net Income 2.51b |
| Net Debt (7.78b) to EBITDA (4.07b): 1.91 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (932.0m) vs 12m ago -2.61% < -2% |
| Gross Margin: 20.25% > 18% (prev 0.22%; Δ 2.00k% > 0.5%) |
| Asset Turnover: 139.8% > 50% (prev 138.4%; Δ 1.36% > 0%) |
| Interest Coverage Ratio: 6.25 > 6 (EBITDA TTM 4.07b / Interest Expense TTM 502.0m) |
| A: -0.17 (Total Current Assets 22.2b - Total Current Liabilities 29.3b) / Total Assets 41.5b |
| B: -0.06 (Retained Earnings -2.33b / Total Assets 41.5b) |
| C: 0.08 (EBIT TTM 3.14b / Avg Total Assets 40.2b) |
| D: -0.06 (Book Value of Equity -2.32b / Total Liabilities 38.1b) |
| Altman-Z'' = -0.84 = CCC |
| DSRI: 0.74 (Receivables 5.33b/6.90b, Revenue 56.2b/53.9b) |
| GMI: 1.08 (GM 20.25% / 21.85%) |
| AQI: 1.01 (AQ_t 0.39 / AQ_t-1 0.39) |
| SGI: 1.04 (Revenue 56.2b / 53.9b) |
| TATA: -0.03 (NI 2.51b - CFO 3.71b) / TA 41.5b) |
| Beneish M = -3.16 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 24.43 with a total of 29,815,010 shares traded.
Over the past week, the price has changed by +16.78%,
over one month by +23.63%,
over three months by +31.98% and
over the past year by -9.44%.
HP has received a consensus analysts rating of 3.24. Therefore, it is recommended to hold HPQ.
- StrongBuy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 19.7 | -19.4% |
P/E Trailing = 9.5606
P/E Forward = 8.7336
P/S = 0.4121
P/B = 0.6074
P/EG = 2.1834
Revenue TTM = 56.2b USD
EBIT TTM = 3.14b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 8.84b USD (from longTermDebt, last quarter)
Short Term Debt = 861.0m USD (from shortTermDebt, last quarter)
Debt = 10.9b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.24b
Net Debt = 7.78b USD (calculated: Debt 10.9b - CCE 3.15b)
Enterprise Value = 31.0b USD (23.2b + Debt 10.9b - CCE 3.15b)
Interest Coverage Ratio = 6.25 (Ebit TTM 3.14b / Interest Expense TTM 502.0m)
EV/FCF = 10.76x (Enterprise Value 31.0b / FCF TTM 2.88b)
FCF Yield = 9.30% (FCF TTM 2.88b / Enterprise Value 31.0b)
FCF Margin = 5.12% (FCF TTM 2.88b / Revenue TTM 56.2b)
Net Margin = 4.46% (Net Income TTM 2.51b / Revenue TTM 56.2b)
Gross Margin = 20.25% ((Revenue TTM 56.2b - Cost of Revenue TTM 44.8b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 20.23%)
Tobins Q-Ratio = 0.75 (Enterprise Value 31.0b / Total Assets 41.5b)
Interest Expense / Debt = 4.59% (Interest Expense 502.0m / Debt 10.9b)
Taxrate = 18.78% (126.0m / 671.0m)
NOPAT = 2.55b (EBIT 3.14b * (1 - 18.78%))
Current Ratio = 0.76 (Total Current Assets 22.2b / Total Current Liabilities 29.3b)
Debt / Equity = 3.21 (Debt 10.9b / totalStockholderEquity, last quarter 3.41b)
Debt / EBITDA = 1.91 (Net Debt 7.78b / EBITDA 4.07b)
Debt / FCF = 2.70 (Net Debt 7.78b / FCF TTM 2.88b)
Total Stockholder Equity = 221.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.24% (Net Income 2.51b / Total Assets 41.5b)
RoE = 98.43% (Net Income TTM 2.51b / Total Stockholder Equity 2.55b)
RoCE = 27.55% (EBIT 3.14b / Capital Employed (Equity 2.55b + L.T.Debt 8.84b))
RoIC = 19.50% (NOPAT 2.55b / Invested Capital 13.1b)
WACC = 8.48% (E(23.2b)/V(34.1b) * Re(10.73%) + D(10.9b)/V(34.1b) * Rd(4.59%) * (1-Tc(0.19)))
Discount Rate = 10.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -3.25%
[DCF] Terminal Value 73.15% ; FCFF base≈3.03b ; Y1≈2.74b ; Y5≈2.35b
[DCF] Fair Price = 31.56 (EV 36.6b - Net Debt 7.78b = Equity 28.9b / Shares 914.6m; r=8.48% [WACC]; 5y FCF grow -11.88% → 2.50% )
EPS Correlation: -72.61 | EPS CAGR: -2.55% | SUE: 1.19 | # QB: 1
Revenue Correlation: 25.05 | Revenue CAGR: 0.57% | SUE: 2.68 | # QB: 1
EPS current Quarter (2026-07-31): EPS=0.64 | Chg30d=+1.31% | Revisions=+20% | Analysts=12
EPS current Year (2026-10-31): EPS=2.89 | Chg30d=+0.20% | Revisions=+33% | GrowthEPS=-7.3% | GrowthRev=+2.6%
EPS next Year (2027-10-31): EPS=2.98 | Chg30d=+0.08% | Revisions=+0% | GrowthEPS=+2.9% | GrowthRev=+0.4%
[Analyst] Revisions Ratio: +33%